Clinical trial
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00047099 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00047099 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Breast Cancer |
| Official title | A Randomized Phase III Trial Comparing FEC-Chemotherapy vs. EC-Doc-Chemotherapy in Patients With Primary Breast Cancer |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, docetaxel, epirubicin hydrochloride, fluorouracil, goserelin acetate, tamoxifen citrate, adjuvant therapy, radiation therapy |
| Enrollment | 446 |
| Start date | Aug 1, 2001 |
| Primary completion | Feb 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | May 30, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: